Reported Sep 16, 2026 · Ongoing

Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc.,…

Ajanta Pharma USA Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Ajanta Pharma USA Inc · 400 Crossing Blvd Ste 102 · Bridgewater, NJ · 08807-2863

Is this the product you have?

  • Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only
  • Marketed byAjanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01
Lot codes and dates
    • Lot #: DJ23254
    • Exp. Date 11/30/2026
    • DJ10205
    • Exp. Date 04/30/2027
Amount recalled
403,200 tablets

Where it was sold

  • Nationwide

Why it was recalled

Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Ajanta Pharma USA Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (Enforcement Report)

Read the FDA (weekly enforcement report) notice

Data as of Sep 19, 3:26 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.